Universität zu Köln

Journal Article

Johnson, M. L., Gort, E., Pant, S., Lolkema, M. P., Sebastian, M., Scheffler, M., Hwang, J., Duenzinger, U., Riemann, K., Kitzing, T. and Janne, P. A. (2021). A phase I, open-label, dose-escalation trial of BI 1701963 in patients (pts) with KRAS mutated solid tumours: A snapshot analysis. Ann. Oncol., 32. S. S591 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041